BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
24 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
19 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
BioSig Technologies to Present at the Dawson James Small Cap Growth Conference
13 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Telemedicine Technology Joint Venture Announced Between Cytta Corp and Cardiocomm Solutions
12 oct. 2017 07h30 HE
|
Cytta Corp.
Palm Desert, CA, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytta Corp. (OTCPINK:CYCA), a leading provider of mobile smartphone and web based healthcare technology solutions, and CardioComm Solutions, Inc....
BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer
11 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
The Adult Congenital Heart Association (ACHA) Launches National Accreditation Program
14 sept. 2017 10h30 HE
|
Adult Congenital Heart Association
Philadelphia, Pa., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Individuals with congenital heart disease (CHD), the most common birth defect diagnosed in one in 100 births, are living longer. In fact, there...
BioSig Technologies Enters into Strategic Development Work with Health Research International
11 juil. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, July 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Novel Findings Obtained with the PURE EP System to be Presented at American Heart Association’s BCVS Scientific Sessions 2017
26 juin 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, June 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies’ CEO, Ken Londoner Interviewed by Medgadget
13 juin 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, June 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Launches New Corporate Website
08 juin 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, June 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...